Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co‐morbid depressive disorder: a randomized, double‐blind study
- 10 March 2008
- journal article
- research article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 23 (4) , 313-319
Abstract
Objective: Studies indicate that serotoninergic and noradrenergic pathophysiological mechanisms may underlie both alcohol abuse/dependence and depressive disorder. The purpose of this study was to evaluate and compare the effectiveness and tolerability of two serotonergic and noradrenergic antidepressant drugs‐mirtazapine and amitriptyline, for the treatment of patients with alcohol dependence co‐morbid with depressive disorder in a randomized, double‐blind treatment setting.Methods: Forty‐four patients were included in the study. Twenty‐four patients were randomized to mirtazapine and twenty to amitriptyline groups. Thirty‐six of them completed the study. The 17‐item Hamilton Depression Rating Scale (HDRS), the Spielberger State‐Trait Anxiety Inventory (STAI) and alcohol craving questionnaire were used at baseline and, at days 7, 14, 28, 42, and 56 to estimate the effectiveness of the antidepressant treatment. Michigan Alcoholism Screening Test (MAST) was used in the assessment of alcohol dependence. The tolerability was assessed with the Udvalg for Kliniske Undersogelser Side Effect Rating Scale (UKU).Results: There was significant improvement in HDRS and alcohol craving scores with both the drugs. However there were no statistical differences between treatment groups. Mirtazapine was tolerated better than amitriptyline treatment.Conclusions: The treatment with either mirtazapine or amitriptyline resulted with the reduction of HDRS and craving scores. The side‐effect profile of mirtazapine was relatively favorable in our study. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 31 references indexed in Scilit:
- Mirtazapine for Alcohol DependenceThe Journal of Clinical Psychiatry, 2005
- Efficacy of antidepressants in substance use disorders with and without comorbid depressionDrug and Alcohol Dependence, 2005
- Mirtazapine Improves Alcohol DetoxificationJournal of Psychopharmacology, 2004
- The Metabolic Fate of Amitriptyline, Nortriptyline and Amitriptylinoxide in ManDrug Metabolism Reviews, 2004
- Sertraline and Cognitive Behavioral Therapy for Depressed Alcoholics: Results of A Placebo-Controlled TrialJournal of Clinical Psychopharmacology, 2003
- Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depressionInternational Clinical Psychopharmacology, 1996
- Serotonin and alcohol intake, abuse, and dependence: Findings of animal studiesBiological Psychiatry, 1994
- Tianeptine and AmitriptylineNeuropsychobiology, 1988
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960